Sino Biopharmaceutical's total assets for Q2 2024 were ¥66.70B, a decrease of 0.00% from the previous quarter. HK:1177 total liabilities were ¥24.58B for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.